Abstract
218P Clinical effectiveness of tislelizumab combined with gemcitabine/cisplatin (GC) versus GC as adjuvant therapy in high-risk muscle-invasive urothelial carcinoma (MIUC): A real-world study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have